Estrogen Metabolism–Related Genes and Breast Cancer Risk: The Multiethnic Cohort Study
Open Access
- 1 August 2005
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 14 (8), 1998-2003
- https://doi.org/10.1158/1055-9965.epi-05-0076
Abstract
Common polymorphisms in genes that affect estrogen levels may be associated with breast cancer risk. We investigated the associations between breast cancer and sequence variants in several genes in the estradiol/estrone metabolism pathway (CYP1A1*2A, CYP1A2*1F, CYP1B1 Leu432Val, CYP3A4*1B, COMT Val158Met, SULT1A1Arg213His) as well as the Arg554Lys variant in AHR (a transcription factor for CYP1A1, CYP1A2, and CYP1B1) in a case-control study of 1,339 breast cancer cases and 1,370 controls nested in the Multiethnic Cohort Study. The Multiethnic Cohort Study is a large prospective study of men and predominantly postmenopausal women of Japanese, White, African American, Latino, and Native Hawaiian ancestry, residing in Hawaii and Los Angeles. We found no association between breast cancer and these polymorphisms, except for CYP1A2*1F which was inversely associated with risk. The odds ratio (95% confidence interval) for the AA, AC, and CC genotype was 1.0, 0.9 (0.7-1.0), and 0.7 (0.5-1.0), respectively (P for gene dosage effect = 0.03). This association seemed somewhat stronger for estrogen receptor (ER)/progesterone receptor (PR)–negative tumors than for ER/PR-positive tumors, and no statistically significant interaction with estrogen-related risk factors was detected. The findings provide no evidence for a role of COMT Val58Met, CYP1A1*2A, CYP3A4*1B, CYP1B1 Leu432Val, SULT1A1 Arg213His, and AHR Arg554Lys in breast cancer etiology. They also provide support for an inverse association between CYP1A2*1F and breast cancer, which is consistent with the observation of lower circulating estrogen levels in premenopausal women with the CC genotype in a previous study.Keywords
This publication has 33 references indexed in Scilit:
- Association of Genetic Polymorphisms with Serum Estrogens Measured Multiple Times During a 2-Year Period in Premenopausal WomenCancer Epidemiology, Biomarkers & Prevention, 2005
- An investigation of mammographic density and gene variants in healthy womenInternational Journal of Cancer, 2004
- Functional significance of a C→A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeineBritish Journal of Clinical Pharmacology, 1999
- Functional role of estrogen metabolism in target cells: review and perspectivesCarcinogenesis: Integrative Cancer Research, 1998
- Estrogen receptor status of breast cancer: a marker of different stages of tumor or different entities of the disease?Medical Hypotheses, 1997
- Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disordersPharmacogenetics, 1996
- Molecular Mechanisms of Estrogen CarcinogenesisAnnual Review of Pharmacology and Toxicology, 1996
- Polymorphisms of human Ah receptor gene are not involved in lung cancerPharmacogenetics, 1995
- Elevated Estrogen 16 -Hydroxylase Activity: Is This a Genotoxic or Nongenotoxic Biomarker in Human Breast Cancer Risk?JNCI Journal of the National Cancer Institute, 1993
- ‘Hormonal’ risk factors, ‘breast tissue age’ and the age-incidence of breast cancerNature, 1983